Credits: 1.0

Update on Advanced Anti-CD20 Therapeutics to Improve Outcomes for Patients with Multiple Sclerosis

Update on Advanced Anti-CD20 Therapeutics to Improve Outcomes for Patients with Multiple Sclerosis

Early, Optimal Management of CKD and Cardiorenal Disease to Prevent Disease Progression and Improve Outcomes

Hypertrophic Cardiomyopathy: New Evidence, Updated Guidelines to Support Optimal Management

Hypertrophic Cardiomyopathy: New Evidence, Updated Guidelines to Support Optimal Management

Journal Club: The 2023 WHF Consensus Document on ATTR-CM

Code ICH: A Call to Action

Notable Highlights “LIVE” from ACC24: Advances in Non-Statin Lipid Therapy

Strategies to Coordinate the Multidisciplinary Team for Secondary Prevention, Long-Term Treatment, and the Assessment of Bleeding Risk

Advances in Disease Management of Generalized Myasthenia Gravis by Reducing Levels of IgG Autoantibodies